Advanced Search
Contact | Corporate | Help

Safety and Pharmacokinetic Study of EO9(Intravesical Instillation)

Sponsors:
  • Handok Pharmaceuticals Co., Ltd.
Phases:
  • Phase I
IndicationsAcronym:
  • Bladder Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: EO9(Apaziquone)
Enrollment:
6

Additional information about NCT01373398.


SourceSolution © 2008-2012